Home
>
National Drug Code (NDC)
>
MEPRON
MEPRON - 0173-0665-18 - (atovaquone)
Drug Information of MEPRON
| Product NDC: | 0173-0665 |
| Proprietary Name: | MEPRON |
| Non Proprietary Name: | atovaquone |
| Active Ingredient(s): | 750 mg/5mL & nbsp; atovaquone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of MEPRON
| Product NDC: | 0173-0665 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020500 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19950228 |
Package Information of MEPRON
| Package NDC: | 0173-0665-18 |
| Package Description: | 210 mL in 1 BOTTLE (0173-0665-18) |
NDC Information of MEPRON
| NDC Code | 0173-0665-18 |
| Proprietary Name | MEPRON |
| Package Description | 210 mL in 1 BOTTLE (0173-0665-18) |
| Product NDC | 0173-0665 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | atovaquone |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 19950228 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | ATOVAQUONE |
| Strength Number | 750 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Antimalarial [EPC],Antiprotozoal [EPC] |
